Wells Fargo & Company Boston Scientific Corp Put Options Transaction History

Wells Fargo & Company

  • $407 Billion
  • Q2 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q1 2024

May 10, 2024
SELL
$57.6 - $68.62 $288,000 - $343,100
-5,000 Reduced 22.73%
17,000 $1.16 Million
Q2 2022

Aug 12, 2022
SELL
$35.24 - $47.1 $9.69 Million - $13 Million
-275,000 Reduced 92.59%
22,000 $820,000
Q1 2022

May 16, 2022
BUY
$40.9 - $45.1 $3.97 Million - $4.37 Million
97,000 Added 48.5%
297,000 $13.2 Million
Q2 2020

Aug 13, 2020
BUY
$30.19 - $39.11 $6.04 Million - $7.82 Million
200,000 New
200,000 $56,000

Others Institutions Holding BSX

# of Institutions
1,450
Shares Held
1.21B
Call Options Held
8.14M
Put Options Held
8.3M
View Full List

About BOSTON SCIENTIFIC CORP

BSX Quotes by TradingView
  • Ticker BSX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,431,609,984
  • Market Cap $120B
  • Description
  • Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various ...
More about BSX
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email